Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 416)
Posted On: 05/04/2019 6:19:07 AM
Post# of 154117
Posted By: ohm20
Re: lorbas #2520
It seems that virologic failure is due to outside circumstances not the lack of efficacy. As such I'm sure that will be worked into the protocol.

"“It appears most of the viral load breakouts in patients in the 700 mg dose arm are due to an event such as a flu or vaccination that cause the number of T-cells to rise. With additional T-cells, numerous additional CCR5 co-receptors must be covered by PRO 140 to maintain suppressed HIV viral load. "
https://www.cytodyn.com/media/press-releases/...rapy-trial













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site